Masaru Baba
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: March 10, 2026
Tenofovir alafenamide prevents HBV reactivation in anticancer/immunosuppression: 24-month multicentre prospective study.
Journal: The Journal of infection
Published: November 21, 2025
Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort.
Journal: Scientific reports
Published: September 19, 2025
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Hepatology international
Published: April 30, 2025
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.
Journal: Targeted oncology
Published: August 14, 2024
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC.
Journal: JHEP reports : innovation in hepatology
Published: August 04, 2024
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 23, 2024
Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC.
Journal: Alimentary pharmacology & therapeutics
Published: June 09, 2024
Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-up.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 16, 2024
Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.
Journal: Viruses
Published: December 10, 2022
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
Journal: Journal of medical virology
Published: September 16, 2022
Last Updated: 09/26/2026